olmesartan medoxomil has been researched along with Hyperlipidemias in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quiroz, Y; RodrÃguez-Iturbe, B; Sato, T; Vaziri, ND | 1 |
| Inaba, T; Kato, M; Kitayama, K; Koike, H; Mizuno, M; Sada, T | 1 |
| Chuma, H; Fukushima, Y; Kato, M; Koike, H; Mizuno, M; Sada, T; Terashima, H | 1 |
3 other study(ies) available for olmesartan medoxomil and Hyperlipidemias
| Article | Year |
|---|---|
AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cholesterol, VLDL; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Imidazoles; Male; Olmesartan Medoxomil; Pravastatin; Proteinuria; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Renal Insufficiency; Tetrazoles; Triglycerides | 2004 |
Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Atherosclerosis; Blood Pressure; Chemokine CCL2; Cholesterol; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Imidazoles; Immunohistochemistry; Macrophages; Olmesartan Medoxomil; Pravastatin; Rabbits; Tetrazoles; Tunica Intima | 2005 |
Severity of hyperlipidemia does not affect antiatherosclerotic effect of an angiotensin II receptor antagonist in apolipoprotein E-deficient mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Valve; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cholesterol; Heart Rate; Hyperlipidemias; Imidazoles; Male; Mice; Mice, Inbred C57BL; Olmesartan Medoxomil; Tetrazoles; Triglycerides | 2006 |